Income Statement
BONE BIOLOGICS CORP
BBLG
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Oct 31, 2013 2013 FY | Oct 31, 2012 2012 FY | Oct 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Expenses
|
3.23 | 4.22 | 9.43 | 3.67 | 1.10 | 0.83 | 2.45 | 2.79 | 2.63 | 17.85 | 12.00 | 3.01 | 0.00 | 0.01 | 0.00 |
|
Research & Development
|
1.06 | 2.13 | 6.91 | 1.58 | 0.08 | 0.34 | 1.10 | 0.10 | -1.19 | 11.60 | 3.67 | 0.62 | - | - | - |
|
Selling, General & Administrative
|
2.17 | 2.09 | 2.52 | 2.09 | 1.02 | 0.48 | 1.35 | 2.69 | 3.82 | 6.25 | 8.33 | 1.51 | - | - | - |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-3.23 | -4.22 | -9.43 | -3.67 | -1.10 | -0.83 | -2.45 | -2.79 | -2.63 | -17.85 | -12.00 | -3.01 | 0.00 | -0.01 | 0.00 |
|
Non-Operating Income
|
0.13 | 0.11 | 0.48 | 2.18 | -0.51 | 1.00 | -0.98 | -1.64 | -4.42 | -3.18 | -1.87 | -1.41 | 0.00 | 0.00 | 0.00 |
|
Interest Income
|
0.12 | 0.06 | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - | - | - | - | 1.40 | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | -1.61 | -1.82 | -3.42 | -4.43 | -7.05 | -21.03 | -13.87 | -4.42 | 0.00 | -0.01 | 0.00 |
|
Income Tax Expense
|
- | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-3.11 | -4.11 | -8.95 | -1.48 | -1.61 | -1.82 | 3.42 | 4.43 | -7.05 | -21.03 | -13.88 | -4.42 | -0.01 | -0.01 | 0.00 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Oct 31, 2013 2013 FY | Oct 31, 2012 2012 FY | Oct 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-3.23 | -4.22 | -9.43 | -3.67 | -1.10 | -0.83 | -2.45 | -2.79 | -2.63 | -17.85 | -12.00 | -3.01 | 0.00 | -0.01 | 0.00 |
|
Earnings Per Share (Basic)
|
-2.65 | -4.83 | -34.01 | -0.13 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-2.65 | -4.83 | -34.01 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
1.17 | 1.52 | 0.26 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
1.17 | 1.52 | 0.26 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |